Altrafin AG’s Constellation Brands STZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,750
Closed -$621K 72
2023
Q1
$621K Hold
2,750
0.31% 52
2022
Q4
$637K Hold
2,750
0.37% 53
2022
Q3
$632K Hold
2,750
0.38% 54
2022
Q2
$641K Sell
2,750
-1,250
-31% -$304K 0.35% 57
2022
Q1
$921K Sell
4,000
-3,200
-44% -$739K 0.36% 56
2021
Q4
$1.81M Buy
+7,200
New +$1.64M 0.65% 44

Other funds holding STZ

Altrafin AG's STZ Position: Q2 2023 in Review

Altrafin AG sold out of Constellation Brands (STZ) in Q2 2023, closing a stake of 2,750 shares — an estimated $621K sold.

Altrafin AG first reported a position in STZ in Q4 2021 and held it in 6 quarters. The position peaked at $1.81M in Q4 2021. 1,228 funds tracked by Wall St. Rank hold STZ as of Q2 2023.

  • Altrafin AG reported no remaining Constellation Brands position as of Q2 2023 after selling out during the quarter.
  • Altrafin AG sold 2,750 Constellation Brands shares in Q2 2023, an estimated $621K.
  • Altrafin AG first reported a position in Constellation Brands in Q4 2021 and held it in 6 quarters.
  • Altrafin AG's Constellation Brands position peaked at $1.81M in Q4 2021.
  • 1,228 funds tracked by Wall St. Rank held Constellation Brands as of Q2 2023.

Based on Altrafin AG's 13F filing for Q2 2023, filed 17 Feb 2026.